Key facts
- It has raised $2.2M; the latest was Early Stage VC ($160K) in Dec 2025.
- Notable investors include Plug and Play Tech Center, National Institutes of Health, gener8tor, Peachscore, Activation Capital — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for OrthoPreserve
- ·The full record, as it builds
Funding rounds
No funding rounds for OrthoPreserve are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OrthoPreserve
Developer of a meniscus implant device designed for meniscus injury treatment. The company's implant is intended to replace the damaged meniscus to relieve pain, restore mobility, and prevent the accelerated arthritis development that would normally accompany a meniscectomy, enabling patients to get a quick recovery and healthcare providers to reduce the risk of arthritis and knee replacements in patients with previous meniscus injuries.
- Sector
- Healthcare
- HQ
- Atlanta, GA, United States
- Founded
- 2021
- Employees
- 6
- Website
- orthopreserve.com/
- Ownership
- Privately Held (backing)
OrthoPreserve doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OrthoPreserve shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OrthoPreserve in its N-PORT filings yet. We sweep new filings monthly.